BioSpace News Archive

Controlled release drug delivery is a form of dosage that delivers medication or drug in predetermined manner.

Owing to multiple uses like therapeutic healing if stress, insomnia, digestion and immune system is leading the market to chart a stellar CAGR.

The global respiratory care devices market has been gaining traction in the last few years.

Genentech is also close to completing enrollment of a global randomized, double-blind, placebo-controlled Phase III clinical trial of Actemra in hospitalized patients with severe COVID-19 pneumonia (COVACTA), with results expected this summer

Stallergenes Greer, a worldwide leader in allergen immunotherapy and Anergis, a leader in ultra-fast AIT research and development, announced the results of a joint research study evaluating the effects of second-generation Contiguous Overlapping Peptides allergen immunotherapy in a therapeutic model of birch pollen allergy, with the aim of shortening AIT administration schemes.

Next generation nebulizers are advanced version of conventional nebulizers characterized by increased portability, higher lung deposition, ease of use, and convenience.

The fetal bovine serum market is fairly consolidated with a handful of players holding large stakes therein.

The global RNAi Technology Market is on a trajectory that will take the market worth up to an impressive figure by the end of the forecast period of 2018 to 2028, thanks to a steady growth rate, compounded annually, accelerating the growth momentum.

Disposable oxygen masks provide a medium for transporting breathable oxygen gas from a tank.

NuVasive, Inc. announced the pricing of its offering of $400.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2023 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.